Dr. John Jacoby, MD

NPI: 1790853778
Total Payments
$6,895
2023 Payments
$139.65
Companies
22
Transactions
256
Medicare Patients
1,646
Medicare Billing
$260,052

Payment Breakdown by Category

Food & Beverage$6,742 (97.8%)
Education$152.51 (2.2%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $6,742 250 97.8%
Education $152.51 6 2.2%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $1,480 59 $0 (2023)
Daiichi Sankyo Inc. $1,113 68 $0 (2019)
GlaxoSmithKline, LLC. $932.00 33 $0 (2023)
Boehringer Ingelheim Pharmaceuticals, Inc. $867.51 15 $0 (2019)
Janssen Pharmaceuticals, Inc $525.08 14 $0 (2021)
ABBVIE INC. $499.66 13 $0 (2022)
Merck Sharp & Dohme Corporation $319.92 15 $0 (2019)
Teva Pharmaceuticals USA, Inc. $266.22 4 $0 (2022)
Genentech USA, Inc. $169.34 3 $0 (2020)
ITI, Inc. $155.01 7 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2023 $139.65 6 GlaxoSmithKline, LLC. ($62.61)
2022 $859.63 32 ABBVIE INC. ($357.07)
2021 $537.92 19 GlaxoSmithKline, LLC. ($242.41)
2020 $299.75 11 Genentech USA, Inc. ($149.66)
2019 $966.32 30 Boehringer Ingelheim Pharmaceuticals, Inc. ($261.16)
2018 $1,597 72 Daiichi Sankyo Inc. ($493.50)
2017 $2,495 86 AstraZeneca Pharmaceuticals LP ($547.82)

All Payment Transactions

256 individual payment records from CMS Open Payments — Page 1 of 11

Date Company Product Nature Form Amount Type
10/26/2023 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $15.37 General
Category: Cardiovascular and Metabolism
08/31/2023 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $16.18 General
Category: Cardiovascular and Metabolism
05/10/2023 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $31.96 General
Category: RESPIRATORY
03/23/2023 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $30.65 General
Category: RESPIRATORY
01/19/2023 PFIZER INC. ELIQUIS (Drug), PAXLOVID, NURTEC ODT Food and Beverage In-kind items and services $26.88 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
01/12/2023 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $18.61 General
Category: Respiratory
12/22/2022 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $5.95 General
Category: RESPIRATORY
12/17/2022 IDORSIA PHARMACEUTICALS US INC QUVIVIQ (Drug) Food and Beverage In-kind items and services $23.54 General
Category: INSOMNIA
12/07/2022 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $11.92 General
Category: Cardiovascular and Metabolism
10/13/2022 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $19.61 General
Category: Respiratory
10/04/2022 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $17.87 General
Category: NEUROSCIENCE
09/27/2022 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $14.03 General
Category: NEUROSCIENCE
09/22/2022 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $16.53 General
Category: Respiratory
09/09/2022 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $26.50 General
Category: NEUROSCIENCE
08/18/2022 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $14.25 General
Category: RESPIRATORY
08/15/2022 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) Food and Beverage In-kind items and services $23.12 General
Category: Central Nervous System
08/01/2022 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $17.06 General
Category: Respiratory
07/28/2022 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $15.78 General
Category: NEUROSCIENCE
07/25/2022 ITI, Inc. CAPLYTA (Drug) Food and Beverage In-kind items and services $24.55 General
Category: PSYCHIATRY
07/18/2022 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $15.38 General
Category: Respiratory
07/13/2022 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $8.53 General
Category: NEUROSCIENCE
07/06/2022 ITI, Inc. CAPLYTA (Drug) Food and Beverage In-kind items and services $21.58 General
Category: PSYCHIATRY
06/08/2022 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $25.62 General
Category: NEUROSCIENCE
05/25/2022 ITI, Inc. CAPLYTA (Drug) Food and Beverage In-kind items and services $21.51 General
Category: PSYCHIATRY
05/19/2022 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $14.89 General
Category: Respiratory

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 8 377 903 $127,501 $59,465
2022 8 369 871 $120,135 $58,999
2021 7 405 987 $129,675 $61,473
2020 7 495 1,165 $174,283 $80,115
Total Patients
1,646
Total Services
3,926
Medicare Billing
$260,052
Procedure Codes
30

All Medicare Procedures & Services

30 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 107 414 $64,170 $29,017 45.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 64 178 $30,616 $19,496 63.7%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 50 97 $9,603 $4,533 47.2%
94060 Test to measure expiratory airflow and volume changes before and after medication administration Office 2023 60 91 $14,196 $2,936 20.7%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 11 11 $1,650 $1,617 98.0%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 57 84 $6,384 $1,002 15.7%
G0008 Administration of influenza virus vaccine Office 2023 17 17 $442.00 $433.16 98.0%
90694 Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage Office 2023 11 11 $440.00 $431.20 98.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 114 475 $73,625 $37,326 50.7%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 68 140 $13,860 $7,310 52.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 40 62 $10,664 $6,857 64.3%
94060 Test to measure expiratory airflow and volume changes before and after medication administration Office 2022 57 86 $13,416 $3,013 22.5%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 20 20 $3,000 $2,957 98.6%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2022 44 62 $4,712 $817.18 17.3%
90756 Influenza vaccine, quadrivalent derived from cell cultures Office 2022 13 13 $520.00 $388.01 74.6%
G0008 Administration of influenza virus vaccine Office 2022 13 13 $338.00 $331.76 98.2%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 109 473 $73,315 $38,985 53.2%
99212 Established patient outpatient visit, total time 10-19 minutes Office 2021 96 240 $23,760 $9,453 39.8%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 25 35 $6,020 $4,238 70.4%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2021 24 24 $3,600 $3,600 100.0%
94060 Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration Office 2021 60 93 $14,508 $3,550 24.5%
93000 Routine ekg using at least 12 leads including interpretation and report Office 2021 75 106 $8,056 $1,320 16.4%
G0008 Administration of influenza virus vaccine Office 2021 16 16 $416.00 $326.08 78.4%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 129 538 $92,536 $48,392 52.3%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 120 287 $44,485 $18,345 41.2%

About Dr. John Jacoby, MD

Dr. John Jacoby, MD is a General Practice healthcare provider based in New Rochelle, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790853778.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Jacoby, MD has received a total of $6,895 in payments from pharmaceutical and medical device companies, with $139.65 received in 2023. These payments were reported across 256 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($6,742).

As a Medicare-enrolled provider, Jacoby has provided services to 1,646 Medicare beneficiaries, totaling 3,926 services with total Medicare billing of $260,052. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.

Practice Information

  • Specialty General Practice
  • Location New Rochelle, NY
  • Active Since 11/30/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 208D00000X
  • Entity Type Individual
  • NPI Number 1790853778

Products in Payments

  • FARXIGA (Drug) $624.75
  • Morphabond ER (Drug) $593.87
  • Movantik (Drug) $457.15
  • TRELEGY ELLIPTA (Drug) $454.06
  • BEVESPI AEROSPHERE (Drug) $372.63
  • INVOKANA (Drug) $300.62
  • SPIRIVA RESPIMAT (Drug) $269.92
  • VRAYLAR (Drug) $239.32
  • XARELTO (Drug) $224.46
  • ANORO (Drug) $213.28
  • BELSOMRA (Drug) $208.17
  • Xofluza (Drug) $169.34
  • ANORO ELLIPTA (Drug) $167.11
  • CAPLYTA (Drug) $155.01
  • BREZTRI (Drug) $145.00
  • SYMBICORT (Drug) $139.43
  • AUSTEDO (Drug) $137.04
  • AJOVY (Drug) $129.18
  • Humira (Biological) $117.59
  • QULIPTA (Drug) $108.87

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

General Practice Doctors in New Rochelle